Credent Connect N Care IPO Details

SME NSE

Credent Connect N Care IPO Summary

Credent Connect N Care Logo | Credent Connect N Care IPO Details, Date, Price, GMP, Live Subscription

Credent Connect N Care IPO opens for subscription on 13 Aug 2026 and closes on 17 Aug 2026.The IPO will be listed on NSE with the tentative listing date set for 20 Aug 2026.

Credent Connect N Care IPO price band has been fixed at ₹179 – ₹189 per share. The face value is ₹10 per share with a lot size of 600.

Credent Connect N Care IPO total issue size comprises 49,68,000 shares (aggregating up to ₹93.90 Cr). This includes a fresh issue of 49,68,000 shares (aggregating up to ₹93.90 Cr). Pre-issue shareholding stands at 1,32,54,900, which will increase to 1,82,22,900 post-issue.

Credent Connect N Care IPO carries a ₹92 (48.68%) GMP, reflecting investor sentiment.

Credent Connect N Care IPO Lot Size :Individual Minimum is 2 lots (1,200 shares) amounting to ₹2,26,800. Individual Maximum is 2 lots (1,200 shares) amounting to ₹2,26,800. SHNI Minimum is 3 lots (1,800 shares) amounting to ₹3,40,200. SHNI Maximum is 8 lots (4,800 shares) amounting to ₹9,07,200. BHNI Minimum is 9 lots (5,400 shares) amounting to ₹10,20,600.

The Lead Managers for Credent Connect N Care IPO are crucial for the offering's success. They are responsible for a wide range of tasks, including preparing the company for the public market, managing the regulatory filings, and marketing the IPO to potential investors. The lead manager for this offering is Hem Securities Ltd . To assess their past performance and success in previous IPOs, you can view the Lead Manager Performance Summary report.

For SME (Small and Medium-sized Enterprise) IPOs, a Market Maker is appointed to ensure liquidity and stability for the stock once it is listed. They do this by continuously quoting bid and ask prices, ensuring there is a market for the shares. The appointed market maker for this IPO is Hem Finlease. You can analyze their track record by checking the Market Maker Performance Summary report.

For detailed information, Refer to the Credent Connect N Care Limited RHP.

Credent Connect N Care IPO Details

Listing Price : ₹359.1 at a Premium of 90%
Open Date
13 Aug 2026
Close Date
17 Aug 2026
Listing Date
20 Aug 2026
Issue Price
₹179 - ₹189
Face Value
₹10 per share
Lot Size
600 Shares
GMP
₹92(48.68%)
Issue Type
IPO
Listing On
NSE
Type
Book Built Issue
Pre-issue Shareholding
1,32,54,900 shares
Post-issue Shareholding
1,82,22,900 shares
Total Issue Size
49,68,000 shares(aggregating up to ₹93.90 Cr)
Fresh Issue
49,68,000 shares(aggregating up to ₹93.90 Cr)
Offer for Sale
-

Credent Connect N Care IPO Subscription

Credent Connect N Care IPO Application Wise Breakup

Credent Connect N Care IPO Dates

  • 13 Aug 2026
    Opening dateOpen
  • 17 Aug 2026
    Closing dateClose
  • 18 Aug 2026
    Allotment Date Allotment
  • 19 Aug 2026
    Initiation of RefundsRefund
  • 19 Aug 2026
    Credit of SharesCredit
  • 20 Aug 2026
    Listing dateListing

Credent Connect N Care IPO Lot Size

ApplicationLotsSharesAmount
Individual Minimum21200₹2,26,800
Individual Maximum21200₹2,26,800
SHNI Minimum31800₹3,40,200
SHNI Maximum84800₹9,07,200
BHNI Minimum95400₹10,20,600

Credent Connect N Care IPO Reservation

Promoter Holding

Pre Issue:
87.64%
Post Issue:
63.75%
Promoter Names:
Ashok Kumar Sharma, Karan Sharma, Tarun Sharma, Dimple Sharma, Tanveen

Credent Connect N Care IPO Valuations

ROE38.61%
ROCE24.22%
RoNW32.36%
PAT Margin8.45%
EBITDA Margin13.13%

Credent Connect N Care Financial Information

Period Ended31 Mar 202531 Mar 2024
Assets29.5026.41
Total Income78.2376.02
Profit After Tax2.252.66
EBITDA4.994.30
NET Worth15.9013.66
Reserves and Surplus15.7013.46
Total Borrowing7.426.85
Amount in ₹ Crore

About Credent Connect N Care IPO

Credent Connect N Care Limited, incorporated in 2015 and headquartered in New Delhi, India, is a transport and logistics company operating as an unlisted public limited entity registered with the Registrar of Companies (ROC), Delhi.

The company is engaged in providing integrated logistics and supply chain solutions, including cold chain logistics, warehousing, transportation, and distribution services. It primarily caters to sectors such as healthcare, e-commerce, and business support services, offering specialized and time-sensitive delivery capabilities.

Credent Connect N Care Limited operates as a business-to-business (B2B) service provider, delivering end-to-end solutions that integrate logistics, technology, and healthcare support services. Its offerings include transport support services, courier operations, and administrative support services tailored to client requirements.

A key focus area for the company is healthcare logistics, where it provides B2B services involving the transportation of diagnostic samples from collection centers to laboratories and between healthcare facilities. It also supports IVD (In Vitro Diagnostics) companies by facilitating the movement of reagents from clearing and forwarding (C&F) agents to laboratories, ensuring timely and secure handling of critical medical supplies.

The company also operates a technology-enabled courier aggregation platform, “C3 Post”, which offers pan-India pin-code coverage for bulk shipping requirements, enhancing its service reach and operational efficiency.

Credent Connect N Care Limited continues to strengthen its position in the logistics ecosystem by focusing on specialized healthcare logistics and technology-driven supply chain solutions.

Strength Of Credent Connect N Care IPO

  • Comprehensive Healthcare Ecosystem and Logistics Platform.
  • Well established relationships with clients .
  • Leveraging the experience of our Promoters and Directors .
  • Widespread reach in domestic markets.

Risk Of Credent Connect N Care IPO

  • We derive a significant portion of our revenue from operations from our top 10 customers with which we do not have any firm commitments. The loss of any one or more of our major customers would have a material adverse effect on our business, cash flows, results of operations and financial condition.
  • Our business is dependent on diagnostic and healthcare companies, and any reduction in their testing volumes, outsourcing requirements, or adverse sector developments could materially and adversely affect our business, financial condition, and results of operations.
  • We are exposed to risks relating to loss, damage, contamination or delay in transportation of diagnostic samples, which could result in client claims, financial liabilities and reputational harm.
  • Our business depends on service-level contracts with clients that are subject to renewal, renegotiation and termination, and our inability to maintain or renew such contracts on favourable terms could materially and adversely affect our business.
  • Our business is working capital intensive and trade receivables constitute a significant portion of our current assets. Any delay or failure in realisation of trade receivables could adversely affect our cash flows, liquidity and financial condition.
  • Our business is highly dependent on the availability and performance of a large, skilled and geographically dispersed workforce, and our inability to effectively manage, train and retain such personnel could adversely affect our operations.
  • Our operations depend on the continuous availability of specialised packaging materials and consumables, and any disruption in their supply or increase in their cost could adversely affect our service delivery and profitability.
  • Misconduct, fraud, negligence or theft by our field personnel could adversely affect our business, reputation and financial condition
  • Our subsidiary companies has incurred losses and had a negative net worth in the past, and any future losses may adversely affect its financial condition and our consolidated results.
  • We rely on financing from banks or financial institutions to carry on our business operations, and inability to obtain additional financing on terms favorable to us or at all could have an adverse impact on our financial condition. If we are unable to raise additional capital, our business and future financial performance could be adversely affected.

Objectives Credent Connect N Care IPO

1. Investment in the wholly owned subsidiary, Credent Healthcare Private Limited to meet its working capital requirement

2. Investment in the wholly owned subsidiary, Credent Healthcare Private Limited to finance its capital expenditure requirements for machinery

3. To meet Working Capital Requirements

4. Repayment and/or repayment, in full or part, of borrowing availed by the Company

5. General corporate purposes


Company Contact Details

B-3, Second Floor, Nimri Commercial Complex, Ashok Vihar, Phase-4,
Delhi, New Delhi , 110052
Phone: +91-9971777199
Email: cs@c3logistics.co.in
Website: https://c3logistics.co.in/

Registrar Contact Details

Name:
Kfin Technologies Ltd
Phone:
+91-40-67162222

Credent Connect N Care FAQs

The Credent Connect N Care IPO is a SME public issue comprising 4968000 equity shares with a face value of ₹10 each, aggregating to a total issue size of ₹93.90 Cr. The issue price has been fixed at ₹189 per equity share, and the minimum application size is 600 shares.

The IPO opens for subscription on 13 Aug 2026, and closes on 17 Aug 2026.

Kfin Technologies Ltd has been appointed as the registrar to the issue. The equity shares are proposed to be listed on the NSE

The Credent Connect N Care IPO opens on 13 Aug 2026.

Credent Connect N Care IPO lot size is 600, and the minimum amount required for application is ₹113400.

You may apply for the Credent Connect N Care IPO online by using either the UPI or ASBA payment method. The ASBA facility is available through the net banking platform of your respective bank. The UPI-based IPO application option is typically provided by brokers that do not offer banking services. For detailed guidance on the online IPO application process, please refer to the procedures outlined by Zerodha, Groww, Upstox, 5Paisa, Paytm Money, Fyers, Alice Blue, Nuvama, HDFC Bank, ICICI Direct, Kotak Securities, Axis Direct, and SBI Bank.

The Basis of Allotment for the Credent Connect N Care IPO is scheduled to be finalized on 18 Aug 2026. Subsequently, the shares allotted will be credited to investors’ demat accounts by 19 Aug 2026. Investors are advised to regularly check the Credent Connect N Care IPO allotment status for updates.

The listing date for the Credent Connect N Care IPO has not yet been officially announced. However, the tentative listing date is scheduled for 20 Aug 2026.

Credent Connect N Care IPO Grey Market Premium (GMP) refers to the unofficial price at which the company’s IPO shares are traded in the grey market prior to their listing on the stock exchange. The GMP serves as an indicator of investor demand, expected listing gains, and the overall market sentiment toward the IPO.

As of now, the current GMP stands at ₹92 (48.68%).

Comments

Download A2ZIPO App for Live IPO Subscription and GMPA2ZIPO - Get Latest Mainboard and SME IPO Details